DV
Dividend Vision

CMND — Clearmind Medicine Inc. Common Shares

Clearmind Medicine Inc. Common Shares (CMND)

Its deepest 1-year drawdown was 99.7%.

Clearmind Medicine Inc. is a clinical-stage pharmaceutical company developing novel psychedelic-based medicines to treat alcohol use disorders, eating disorders, obesity, depression, anxiety, and post-traumatic stress disorder, with its lead candidate CM-CMND-001 currently in Phase I/IIa clinical trials. The company does not currently distribute dividends. This security appeals to investors with a high risk tolerance who are interested in early-stage pharmaceutical development rather than current income generation.

CMND key facts

Asset type
Stock
Asset class
Equity
Inception date
08/16/2021
Last close
$1.86
Market cap
$2,881,969
Average volume
36300.0
Beta
-1.191
Payout ratio
0.0
Forward P/E
0.0
EPS
$-175.92